| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.29e-07 | 3 | 102 | 3 | GO:0008332 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.66e-06 | 46 | 102 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.52e-05 | 14 | 102 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | protein tyrosine/serine/threonine phosphatase activity | 6.80e-05 | 43 | 102 | 4 | GO:0008138 | |
| GeneOntologyMolecularFunction | MAP kinase phosphatase activity | 9.99e-05 | 18 | 102 | 3 | GO:0033549 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.25e-04 | 151 | 102 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.30e-04 | 152 | 102 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | cAMP binding | 2.74e-04 | 25 | 102 | 3 | GO:0030552 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.09e-04 | 26 | 102 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 3.35e-04 | 337 | 102 | 8 | GO:0031625 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.45e-04 | 182 | 102 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.65e-04 | 184 | 102 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 5.01e-04 | 358 | 102 | 8 | GO:0044389 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.26e-04 | 129 | 102 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 7.09e-04 | 8 | 102 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | AMBP PRPSAP2 ANXA1 MCF2L2 NLRC4 SLIT2 WASH6P RASGRP1 WASH3P FRY MYOZ1 DENND2C PRKAR1A PRKAR1B ARHGEF2 RAPGEF2 NCKAP1L | 8.08e-04 | 1418 | 102 | 17 | GO:0030234 |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | AMBP PRPSAP2 ANXA1 MICU1 SLIT2 FRY KCNE4 MYOZ1 PRKAR1A PRKAR1B | 9.44e-04 | 596 | 102 | 10 | GO:0140678 |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.03e-03 | 39 | 102 | 3 | GO:0030551 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase inhibitor activity | 1.13e-03 | 10 | 102 | 2 | GO:0004862 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.35e-03 | 323 | 102 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | chondroitin sulfate binding | 1.38e-03 | 11 | 102 | 2 | GO:0035374 | |
| GeneOntologyMolecularFunction | calcium ion binding | ANXA1 CPS1 SLC25A25 MICU1 SLIT2 RASGRP1 ATP2C1 BRAF SCUBE3 RAPGEF2 TNNC1 | 1.54e-03 | 749 | 102 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 1.75e-03 | 435 | 102 | 8 | GO:0004857 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 1.89e-03 | 48 | 102 | 3 | GO:0008200 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.93e-03 | 103 | 102 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 1.94e-03 | 13 | 102 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase regulator activity | 1.94e-03 | 13 | 102 | 2 | GO:0008603 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 2.13e-03 | 50 | 102 | 3 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 2.26e-03 | 51 | 102 | 3 | GO:0141110 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.26e-03 | 51 | 102 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.37e-03 | 109 | 102 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.39e-03 | 52 | 102 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 2.86e-03 | 189 | 102 | 5 | GO:0004721 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 2.96e-03 | 16 | 102 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 2.96e-03 | 16 | 102 | 2 | GO:0034236 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 3.26e-03 | 58 | 102 | 3 | GO:0051018 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ANXA1 SLIT2 WASH6P WASH3P KCNE4 ATP2C1 CSF1R BRAF MYOZ1 SSH1 TLN1 PRKAR1A CACNA1H CACNA1G ARHGEF2 TNNC1 MYBPC1 NCKAP1L | 3.53e-07 | 912 | 100 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | ANXA1 SLIT2 WASH6P WASH3P ATP2C1 CSF1R BRAF MYOZ1 SSH1 TLN1 PRKAR1A ARHGEF2 MYBPC1 NCKAP1L | 3.25e-05 | 803 | 100 | 14 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of cAMP-dependent protein kinase activity | 5.91e-05 | 16 | 100 | 3 | GO:2000479 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | CUL4A RARA ANXA1 DUSP3 RNF8 WASH6P RASGRP1 WASH3P EFNB1 CSF1R BRAF SUPT6H PRKAR1A PHF14 NCKAP1L | 7.01e-05 | 976 | 100 | 15 | GO:0046649 |
| GeneOntologyCellularComponent | calcium channel complex | 2.89e-05 | 73 | 102 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 7.30e-05 | 17 | 102 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 7.45e-05 | 46 | 102 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.76e-04 | 29 | 102 | 3 | GO:0034706 | |
| MousePheno | abnormal depression-related behavior | 3.55e-05 | 156 | 82 | 7 | MP:0003360 | |
| MousePheno | abnormal coping response | 4.15e-05 | 66 | 82 | 5 | MP:0003062 | |
| MousePheno | increased coping response | 5.62e-05 | 36 | 82 | 4 | MP:0003063 | |
| MousePheno | abnormal ectoplacental cavity morphology | 8.41e-05 | 15 | 82 | 3 | MP:0011202 | |
| MousePheno | abnormal cardiogenic plate morphology | 1.02e-04 | 3 | 82 | 2 | MP:0012498 | |
| MousePheno | decreased depression-related behavior | 1.25e-04 | 44 | 82 | 4 | MP:0014413 | |
| Domain | VDCC_T_a1 | 1.36e-07 | 3 | 97 | 3 | IPR005445 | |
| Domain | VDCCAlpha1 | 1.59e-05 | 10 | 97 | 3 | IPR002077 | |
| Domain | DUSP | 1.93e-05 | 31 | 97 | 4 | IPR024950 | |
| Domain | TYR_PHOSPHATASE_DUAL | 2.81e-05 | 34 | 97 | 4 | PS50054 | |
| Domain | DSPc | 3.16e-05 | 35 | 97 | 4 | SM00195 | |
| Domain | TYR_PHOSPHATASE_DUAL_dom | 3.16e-05 | 35 | 97 | 4 | IPR020422 | |
| Domain | Dual-sp_phosphatase_cat-dom | 5.97e-05 | 41 | 97 | 4 | IPR000340 | |
| Domain | DSPc | 5.97e-05 | 41 | 97 | 4 | PF00782 | |
| Domain | TYR_PHOSPHATASE_1 | 8.51e-05 | 86 | 97 | 5 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 8.99e-05 | 87 | 97 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 8.99e-05 | 87 | 97 | 5 | PS50056 | |
| Domain | - | 1.17e-04 | 92 | 97 | 5 | 3.90.190.10 | |
| Domain | cAMP_dep_PK_reg_su | 1.59e-04 | 4 | 97 | 2 | IPR012198 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.66e-04 | 99 | 97 | 5 | IPR029021 | |
| Domain | Atypical_DUSP_famA | 2.64e-04 | 5 | 97 | 2 | IPR020405 | |
| Domain | RIIa | 3.95e-04 | 6 | 97 | 2 | SM00394 | |
| Domain | Cullin_CS | 5.51e-04 | 7 | 97 | 2 | IPR016157 | |
| Domain | CULLIN | 5.51e-04 | 7 | 97 | 2 | SM00182 | |
| Domain | RIIa | 5.51e-04 | 7 | 97 | 2 | PF02197 | |
| Domain | Tyr_Pase_AS | 5.66e-04 | 73 | 97 | 4 | IPR016130 | |
| Domain | cNMP | 7.23e-04 | 34 | 97 | 3 | SM00100 | |
| Domain | EF-hand_8 | 7.23e-04 | 34 | 97 | 3 | PF13833 | |
| Domain | cNMP_binding | 7.23e-04 | 34 | 97 | 3 | PF00027 | |
| Domain | Cullin_neddylation_domain | 7.32e-04 | 8 | 97 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 7.32e-04 | 8 | 97 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 7.32e-04 | 8 | 97 | 2 | SM00884 | |
| Domain | cNMP-bd_dom | 7.88e-04 | 35 | 97 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 7.88e-04 | 35 | 97 | 3 | PS50042 | |
| Domain | Cullin_homology | 9.39e-04 | 9 | 97 | 2 | IPR016158 | |
| Domain | cNMP-bd-like | 1.00e-03 | 38 | 97 | 3 | IPR018490 | |
| Domain | Cullin | 1.17e-03 | 10 | 97 | 2 | PF00888 | |
| Domain | CULLIN_2 | 1.17e-03 | 10 | 97 | 2 | PS50069 | |
| Domain | Cullin_N | 1.17e-03 | 10 | 97 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 1.17e-03 | 10 | 97 | 2 | PS01256 | |
| Domain | Cullin_repeat-like_dom | 1.70e-03 | 12 | 97 | 2 | IPR016159 | |
| Domain | - | 1.98e-03 | 48 | 97 | 3 | 2.60.120.10 | |
| Domain | Atypical_DUSP | 2.01e-03 | 13 | 97 | 2 | IPR020417 | |
| Domain | RmlC-like_jellyroll | 2.36e-03 | 51 | 97 | 3 | IPR014710 | |
| Domain | cAMP_dep_PK_reg_su_I/II_a/b | 2.68e-03 | 15 | 97 | 2 | IPR003117 | |
| Domain | cNMP-bd_CS | 3.06e-03 | 16 | 97 | 2 | IPR018488 | |
| Domain | C1_1 | 3.24e-03 | 57 | 97 | 3 | PF00130 | |
| Domain | Channel_four-helix_dom | 3.24e-03 | 57 | 97 | 3 | IPR027359 | |
| Domain | - | 3.24e-03 | 57 | 97 | 3 | 1.20.120.350 | |
| Domain | BRCT | 4.31e-03 | 19 | 97 | 2 | PF00533 | |
| Domain | ZF_DAG_PE_1 | 4.50e-03 | 64 | 97 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.50e-03 | 64 | 97 | 3 | PS50081 | |
| Domain | C1 | 4.70e-03 | 65 | 97 | 3 | SM00109 | |
| Domain | RasGEFN | 4.77e-03 | 20 | 97 | 2 | SM00229 | |
| Domain | PE/DAG-bd | 4.90e-03 | 66 | 97 | 3 | IPR002219 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 4.22e-06 | 43 | 80 | 5 | M1429 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.11e-05 | 25 | 80 | 4 | M47948 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.92e-05 | 203 | 80 | 8 | M5485 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | DUSP3 DUSP5 RASGRP1 BRAF CACNA1I CACNA1H CACNA1G RAPGEF2 CACNA2D3 | 1.96e-05 | 267 | 80 | 9 | M10792 |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.81e-05 | 11 | 80 | 3 | MM1521 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M | 2.81e-05 | 11 | 80 | 3 | M47573 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.73e-05 | 12 | 80 | 3 | M7968 | |
| Pathway | WP_MAPK_SIGNALING | 7.53e-05 | 246 | 80 | 8 | M39597 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 1.60e-04 | 19 | 80 | 3 | MM1434 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 1.60e-04 | 19 | 80 | 3 | M8719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 2.87e-04 | 23 | 80 | 3 | M47666 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 4.70e-04 | 6 | 80 | 2 | MM14628 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 5.78e-04 | 29 | 80 | 3 | M39762 | |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 2.60e-08 | 3 | 104 | 3 | 23488970 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 2.60e-08 | 3 | 104 | 3 | 11230107 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 2.60e-08 | 3 | 104 | 3 | 28972185 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 11897840 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 2.60e-08 | 3 | 104 | 3 | 18591418 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 28846697 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 11927664 | ||
| Pubmed | CUL4B PDHA1 ANXA1 NARS1 POGZ ARF3 SUPT6H TLN1 XRN1 UTP20 HADHA RBM34 DNMT1 | 8.20e-08 | 653 | 104 | 13 | 22586326 | |
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 1.04e-07 | 4 | 104 | 3 | 28165634 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.13e-07 | 190 | 104 | 8 | 15161933 | |
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 2.59e-07 | 5 | 104 | 3 | 11701968 | |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 5.16e-07 | 6 | 104 | 3 | 18159949 | |
| Pubmed | 1.44e-06 | 8 | 104 | 3 | 28330839 | ||
| Pubmed | 1.44e-06 | 8 | 104 | 3 | 34478646 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 1.44e-06 | 8 | 104 | 3 | 12761855 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CUL4A CAAP1 RIOK1 PDHA1 TM9SF3 RPS11 NARS1 AASDHPPT ARF3 DAP3 SLC25A10 HADHA ARHGEF2 TAF5 RBM34 DNMT1 | 1.90e-06 | 1318 | 104 | 16 | 30463901 |
| Pubmed | 2.15e-06 | 9 | 104 | 3 | 16382099 | ||
| Pubmed | 3.07e-06 | 10 | 104 | 3 | 24778262 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B CAAP1 ATR PDHA1 POGZ STK10 BRAF SSH1 UTP20 PHF14 ARHGEF2 DNMT1 | 3.61e-06 | 774 | 104 | 12 | 15302935 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RIOK1 ATR PDHA1 TM9SF3 RPS11 POGZ DAP3 SUPT6H TLN1 PRKAR1A UTP20 HADHA RBM34 SOAT1 DNMT1 MYBPC1 | 5.14e-06 | 1425 | 104 | 16 | 30948266 |
| Pubmed | PDHA1 WFS1 ANXA1 RPS11 NARS1 PTPRS SPON1 ATP6V1D TLN1 XRN1 PRKAR1A HADHA ARHGEF2 RAPGEF2 DNAH6 CACNA2D3 | 5.42e-06 | 1431 | 104 | 16 | 37142655 | |
| Pubmed | Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. | 7.02e-06 | 41 | 104 | 4 | 18157088 | |
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 8.86e-06 | 2 | 104 | 2 | 12808460 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 14988077 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 1448119 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21622683 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25071191 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20685979 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 36786913 | ||
| Pubmed | Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. | 8.86e-06 | 2 | 104 | 2 | 27974468 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26627919 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23436820 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31042060 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37861555 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20064923 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22469755 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21079360 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22886848 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29082441 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22574369 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8407966 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 38473715 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 8.86e-06 | 2 | 104 | 2 | 21438841 | |
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 8.86e-06 | 2 | 104 | 2 | 22808078 | |
| Pubmed | Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4DCAF5 ubiquitin ligase. | 1.15e-05 | 15 | 104 | 3 | 29691401 | |
| Pubmed | 1.35e-05 | 259 | 104 | 7 | 31162944 | ||
| Pubmed | SECISBP2L AMBP CAAP1 RIOK1 PDHA1 WFS1 ANXA1 NARS1 POGZ BRAF TLN1 HADHA ARHGEF2 RBM34 DNMT1 | 1.42e-05 | 1371 | 104 | 15 | 36244648 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24327205 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24966091 | ||
| Pubmed | ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment. | 2.65e-05 | 3 | 104 | 2 | 28273450 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 22572848 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 32587774 | ||
| Pubmed | WASH Regulates Glucose Homeostasis by Facilitating Glut2 Receptor Recycling in Pancreatic β-Cells. | 2.65e-05 | 3 | 104 | 2 | 30425062 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 27353765 | ||
| Pubmed | Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling. | 2.65e-05 | 3 | 104 | 2 | 28939058 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 31919478 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 29905030 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 3479018 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 19965660 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 38086439 | ||
| Pubmed | B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1. | 2.65e-05 | 3 | 104 | 2 | 25378232 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 34119472 | ||
| Pubmed | Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels. | 2.65e-05 | 3 | 104 | 2 | 21084288 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 33299036 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 12634056 | ||
| Pubmed | Cullin4B/E3-ubiquitin ligase negatively regulates beta-catenin. | 2.65e-05 | 3 | 104 | 2 | 17954973 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 25825486 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 37739992 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 25225459 | ||
| Pubmed | E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation. | 2.65e-05 | 3 | 104 | 2 | 24452595 | |
| Pubmed | PRPSAP2 PDHA1 WFS1 ANXA1 ADGRB2 AASDHPPT PALMD MICU1 ATP2C1 XRN1 PRKAR1A PRKAR1B HADHA | 3.61e-05 | 1139 | 104 | 13 | 36417873 | |
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 4.51e-05 | 313 | 104 | 7 | 16196087 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CUL4B RPS11 NARS1 AASDHPPT SUPT6H ATP6V1D TLN1 PRKAR1A PRKAR1B DNAH6 DNMT1 | 4.77e-05 | 847 | 104 | 11 | 35235311 |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 31800012 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 32492429 | ||
| Pubmed | The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance. | 5.29e-05 | 4 | 104 | 2 | 31167970 | |
| Pubmed | Cyclic nucleotide mapping of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. | 5.29e-05 | 4 | 104 | 2 | 24605759 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 28655554 | ||
| Pubmed | Alpha/beta-tubulin are A kinase anchor proteins for type I PKA in neurons. | 5.29e-05 | 4 | 104 | 2 | 19056362 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 30945295 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 34420308 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 23275443 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 19818632 | ||
| Pubmed | Localization and quaternary structure of the PKA RIβ holoenzyme. | 5.29e-05 | 4 | 104 | 2 | 22797896 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 32879135 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 22718907 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 5.29e-05 | 4 | 104 | 2 | 21788606 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 22453236 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 24886983 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 22262661 | ||
| Pubmed | 5.34e-05 | 134 | 104 | 5 | 24816145 | ||
| Pubmed | Global identification of modular cullin-RING ligase substrates. | 5.34e-05 | 134 | 104 | 5 | 21963094 | |
| Pubmed | 7.51e-05 | 144 | 104 | 5 | 30585266 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 7.80e-05 | 235 | 104 | 6 | 28378594 | |
| Pubmed | 8.06e-05 | 28 | 104 | 3 | 34163012 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CUL4A PRPSAP2 RIOK1 ANXA1 RPS11 NARS1 CPS1 DAP3 SUPT6H TLN1 SLC25A10 HADHA ARHGEF2 DNMT1 | 8.30e-05 | 1415 | 104 | 14 | 28515276 |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 32466489 | ||
| Pubmed | Cullin 4A and 4B ubiquitin ligases interact with γ-tubulin and induce its polyubiquitination. | 8.80e-05 | 5 | 104 | 2 | 25542213 | |
| Interaction | SIRT7 interactions | CUL4B CUL4A ATR PDHA1 ANXA1 NARS1 POGZ ARF3 SUPT6H TLN1 XRN1 UTP20 HADHA RBM34 DNMT1 | 5.58e-06 | 744 | 103 | 15 | int:SIRT7 |
| GeneFamily | Calcium voltage-gated channel subunits | 2.89e-06 | 26 | 70 | 4 | 253 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 3.00e-05 | 16 | 70 | 3 | 14 | |
| GeneFamily | Cullins | 4.08e-04 | 8 | 70 | 2 | 1032 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP | 1.44e-05 | 198 | 104 | 7 | M8878 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 1.49e-05 | 199 | 104 | 7 | M5620 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_2 | 2.56e-05 | 43 | 104 | 4 | M7343 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-06 | 182 | 103 | 6 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-06 | 186 | 103 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.87e-06 | 187 | 103 | 6 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.87e-06 | 187 | 103 | 6 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.19e-06 | 195 | 103 | 6 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 156 | 103 | 5 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.86e-05 | 163 | 103 | 5 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 164 | 103 | 5 | 45a6d809d92fd4eee906da3c812282bacffc9f2f | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 164 | 103 | 5 | aa4358311fc767c292897e3328309d1bcda392d4 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.21e-05 | 166 | 103 | 5 | da10d0be6b616199d49dd922591c2901f9681583 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.46e-05 | 168 | 103 | 5 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 171 | 103 | 5 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.98e-05 | 172 | 103 | 5 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | Immune_cells-Monocytes|Immune_cells / Lineage and Cell class | 5.12e-05 | 173 | 103 | 5 | 3eced40a65453a023a1673658592e7e2a099119b | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-05 | 174 | 103 | 5 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-05 | 174 | 103 | 5 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-05 | 179 | 103 | 5 | 6d2458a887047b5c20389f08345ff5aac7c683e6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-05 | 181 | 103 | 5 | 8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.68e-05 | 183 | 103 | 5 | c6cac433ea7a3d60728efdc7051e09e01bb3ade5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-05 | 183 | 103 | 5 | d23018193b9c0806e0d1a9ac15e6392eb8e96aaf | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-05 | 183 | 103 | 5 | 92d5a61b57851090eba558f19e2a7010043eff81 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 6.86e-05 | 184 | 103 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.04e-05 | 185 | 103 | 5 | d747bc91fc276f12a5572ab0223fc71f829a5110 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.22e-05 | 186 | 103 | 5 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-05 | 187 | 103 | 5 | 8e1d6d25db5b5c91a651bb2d66edfcf073a31704 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-05 | 188 | 103 | 5 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-05 | 189 | 103 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.78e-05 | 189 | 103 | 5 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.78e-05 | 189 | 103 | 5 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.78e-05 | 189 | 103 | 5 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.38e-05 | 192 | 103 | 5 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 8.80e-05 | 194 | 103 | 5 | 219056d4ad256cda73208b8c570bbf689219df83 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 8.80e-05 | 194 | 103 | 5 | 30f683725cb13ae32ef6846618801ec78e12397d | |
| ToppCell | tumor_Lung-Myeloid_cells-Activated_DCs|tumor_Lung / Location, Cell class and cell subclass | 8.80e-05 | 194 | 103 | 5 | a85d958aff84f2296c330a7dcd442bd2344738df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 195 | 103 | 5 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 195 | 103 | 5 | d9bdb37bc562c42fb73fdc3f4150335511b3ef9b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 195 | 103 | 5 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 9.23e-05 | 196 | 103 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | f73573b5d9c735f2a2c718472b7d12b10f2a3718 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 9.23e-05 | 196 | 103 | 5 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 9.23e-05 | 196 | 103 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC3|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.23e-05 | 196 | 103 | 5 | d4e5b55a32d9c04c6b2ca7806a0d96231918761f | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.46e-05 | 197 | 103 | 5 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.46e-05 | 197 | 103 | 5 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.46e-05 | 197 | 103 | 5 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-05 | 197 | 103 | 5 | 173c0c8de4e69882a9f91189deeb4a651fefe551 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-05 | 197 | 103 | 5 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.69e-05 | 198 | 103 | 5 | 898ef4f02443780f9b1fc08b73a165fda0ca5cde | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-promonocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.69e-05 | 198 | 103 | 5 | a11de3836fc1575bec5f6c701836fe2fb5a1027a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.69e-05 | 198 | 103 | 5 | 42be18aef4f656a86c61630b061826a858c496fd | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.69e-05 | 198 | 103 | 5 | f3346c26b9647a199faf3cd7ab19c3a963dbabc2 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.69e-05 | 198 | 103 | 5 | 49fc6ba574ed5c848eaa329aad1d5c8091c79f47 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 6dc446a5d183b01bdf227e45bd88d0b3d8b1c56a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-05 | 199 | 103 | 5 | c684530d4d8073337379c2a24e5e54297fb13691 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-05 | 199 | 103 | 5 | 994e885b8d1874006302a081d13f1ee881d64612 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | control-Myeloid-CD14_Monocytes_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.92e-05 | 199 | 103 | 5 | 8c14237c3da91d1a4878df489a495408a1e83883 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | bdda59ffa0496256dd7a5937e88baac5c2a656c3 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | dff0be30309b6f5f8757b0378ef05ce97f75dbe8 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B---L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | c3474e8a03ec4869fd3636a5559d36dd9c5fd414 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 5c0c09e7b84fed053b299848bdff63ab842a445c | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-04 | 200 | 103 | 5 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | severe-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-04 | 200 | 103 | 5 | 26e04ea276dbca5cde48335c401269c7123b54d2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 115 | 103 | 4 | 207d464c09caf9be361daa56c83cd7da5cf9ce47 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 8.73e-08 | 3 | 102 | 3 | CID010679219 | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; HL60; HT_HG-U133A | 2.18e-07 | 193 | 102 | 9 | 3028_DN | |
| Drug | Flunarizine | 8.67e-07 | 5 | 102 | 3 | DB04841 | |
| Drug | 3,4-dihydroquinazoline | 1.73e-06 | 6 | 102 | 3 | CID000583065 | |
| Drug | LY215840 | 3.02e-06 | 7 | 102 | 3 | CID000132049 | |
| Drug | Cinnarizine | 7.19e-06 | 9 | 102 | 3 | DB00568 | |
| Drug | guanine | PLCXD2 MCF2L2 PIAS2 CCKAR ARF3 OPRM1 STK10 DAP3 RASGRP1 BRAF PRKAR1A ARHGEF2 RAPGEF2 DNMT1 REV1 | 1.16e-05 | 902 | 102 | 15 | CID000000764 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.21e-05 | 171 | 102 | 7 | 7407_DN | |
| Drug | Mibefradil | 1.40e-05 | 11 | 102 | 3 | DB01388 | |
| Drug | EBNs | 1.40e-05 | 11 | 102 | 3 | CID000150695 | |
| Drug | CNS 1145 | 1.41e-05 | 33 | 102 | 4 | CID000190902 | |
| Drug | IHC-64 | 1.41e-05 | 33 | 102 | 4 | CID000162753 | |
| Drug | AC1NBU2S | 1.46e-05 | 117 | 102 | 6 | CID004473765 | |
| Drug | AC1L2AC7 | 1.46e-05 | 69 | 102 | 5 | CID000068733 | |
| Drug | themisone | 1.86e-05 | 12 | 102 | 3 | CID000016235 | |
| Drug | AC1L2VU3 | 1.86e-05 | 12 | 102 | 3 | CID000129572 | |
| Drug | hydride | PDHA1 AASDHPPT H6PD CPS1 ATP2C1 FAR2 ATP6V1D SLC25A10 CACNA1I CACNA1H CACNA1G HADHA TNNC1 SOAT1 | 2.13e-05 | 835 | 102 | 14 | CID000000783 |
| Drug | Mibefradil | 2.42e-05 | 13 | 102 | 3 | ctd:D020748 | |
| Drug | tetralol | 2.42e-05 | 13 | 102 | 3 | CID000010747 | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 3543_UP | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.83e-05 | 79 | 102 | 5 | CID005287890 | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 4642_DN | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 7331_UP | |
| Drug | Etomidate [33125-97-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 3519_UP | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 3537_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 5002_UP | |
| Drug | lactofen | 3.20e-05 | 81 | 102 | 5 | CID000062276 | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 3360_DN | |
| Drug | caffeine | AMBP PLCXD2 ATP2C1 XRN1 PRKAR1A PHF14 CACNA1I CACNA1H CACNA1G CACNA2D3 MYBPC1 | 4.41e-05 | 562 | 102 | 11 | CID000002519 |
| Drug | isovalerate | 4.53e-05 | 143 | 102 | 6 | CID000010430 | |
| Drug | pentasulfane | 4.69e-05 | 16 | 102 | 3 | CID000448216 | |
| Drug | Zonisamide | 5.67e-05 | 17 | 102 | 3 | DB00909 | |
| Drug | Bay K 8644 | 5.92e-05 | 150 | 102 | 6 | CID000002303 | |
| Drug | SureCN2398996 | 5.94e-05 | 3 | 102 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 5.94e-05 | 3 | 102 | 2 | CID000092154 | |
| Drug | He-O | 6.89e-05 | 49 | 102 | 4 | CID006323367 | |
| Drug | cyclopropanecarboxylic acid | 8.03e-05 | 19 | 102 | 3 | CID000015655 | |
| Drug | loperamide | 1.11e-04 | 105 | 102 | 5 | CID000003954 | |
| Drug | pyraclofos | 1.16e-04 | 106 | 102 | 5 | CID000093460 | |
| Drug | Cinildipine | 1.17e-04 | 56 | 102 | 4 | CID000002752 | |
| Drug | methsuximide | 1.19e-04 | 4 | 102 | 2 | CID000006476 | |
| Drug | nilvadipine | 1.53e-04 | 60 | 102 | 4 | CID000004494 | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 1.57e-04 | 179 | 102 | 6 | 331_DN | |
| Disease | Malignant neoplasm of thyroid | 1.11e-04 | 5 | 99 | 2 | C0007115 | |
| Disease | Mood Disorders | 2.62e-04 | 168 | 99 | 5 | C0525045 | |
| Disease | Liver Cirrhosis, Experimental | ANXA1 PALMD CPS1 STK10 FRY CSF1R ATP6V1D RASSF4 SOAT1 NCKAP1L | 2.77e-04 | 774 | 99 | 10 | C0023893 |
| Disease | motor development measurement | 3.08e-04 | 8 | 99 | 2 | EFO_0008237 | |
| Disease | DNA methylation | ABCA13 SLCO3A1 FRY PTPRS STAG3L4 CACNA1H DNAH6 HCRTR1 CACNA2D3 | 3.67e-04 | 656 | 99 | 9 | GO_0006306 |
| Disease | 1-ribosyl-imidazoleacetate measurement | 3.95e-04 | 9 | 99 | 2 | EFO_0800034 | |
| Disease | colon cancer (implicated_via_orthology) | 6.01e-04 | 11 | 99 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 1.47e-03 | 17 | 99 | 2 | C0153943 | |
| Disease | Dementia | 1.47e-03 | 17 | 99 | 2 | C0497327 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.47e-03 | 17 | 99 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.47e-03 | 17 | 99 | 2 | C0154060 | |
| Disease | susceptibility to chronic sinus infection measurement | 1.57e-03 | 68 | 99 | 3 | EFO_0008419 | |
| Disease | gestational age, birth measurement | 2.24e-03 | 21 | 99 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | Stomach Carcinoma | 2.24e-03 | 21 | 99 | 2 | C0699791 | |
| Disease | Etat Marbre | 2.69e-03 | 23 | 99 | 2 | C0266487 | |
| Disease | Drug toxicity | 2.87e-03 | 84 | 99 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 2.87e-03 | 84 | 99 | 3 | C0041755 | |
| Disease | comparative body size at age 10, self-reported | 2.96e-03 | 420 | 99 | 6 | EFO_0009819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVKKLPLMALSTTMA | 76 | Q6ZT62 | |
| LKKIMDRMTVSTLVL | 56 | P02760 | |
| GSTMKMGSLERKKLR | 1451 | O60241 | |
| TVRDSLKKALMMRGL | 176 | P15056 | |
| DAKAAMAGRLMIRKL | 56 | Q9NRN7 | |
| MAGRLMIRKLVAEKL | 61 | Q9NRN7 | |
| VMLLAKIKMRIGHTV | 2551 | Q96N23 | |
| MKLTRKMVLTRAKAS | 1 | O43822 | |
| RSMVLKLTLRCLVRM | 1276 | P26358 | |
| RRKMILHDLKGTMSL | 2931 | Q8IZF6 | |
| VRTLKIMTRLFRTGM | 251 | Q92974 | |
| MLMGVSSQKISLRLK | 651 | O95267 | |
| KRKLSLGIAFMGMSR | 3981 | Q86UQ4 | |
| SLIGKKEMRILMVGL | 11 | P61204 | |
| LEMRARAIKALMKAG | 341 | Q9H8G2 | |
| SAANLMAKKRVIRML | 301 | P32238 | |
| KLRMTGMALRVVRTD | 41 | Q9UBX3 | |
| VTLALGVMRMVKKRA | 316 | P98194 | |
| SMIVKLVRDKLRVMT | 1036 | O94823 | |
| ELMGRKLRVMRSVNK | 351 | P42696 | |
| KMLMKITDLRSISAK | 376 | P10276 | |
| IIKLTMKFQALRLTM | 296 | Q9H2L5 | |
| MKGVGTRHKALIRIM | 286 | P04083 | |
| GISRKMMAEVVRRKL | 71 | Q8NBL1 | |
| TGRKPRMTKLMNRLL | 371 | Q96K12 | |
| LTALRMRMAKLGKKV | 536 | Q9NP74 | |
| LMILRLKSVRMLSGS | 256 | P35372 | |
| LIGIMLGYMKSKRRE | 101 | Q8WWG9 | |
| TIRKQTFMAMLLKLR | 226 | Q9NPP4 | |
| KRAIRLGGIMLRKMM | 146 | Q9Y692 | |
| MKKGFRETMLQLILS | 846 | Q2LD37 | |
| KTMKLMTLSIRQLGR | 901 | Q86YR7 | |
| KEFVSIMKQRLMRGL | 431 | Q9BPX6 | |
| KRMTIIGVILSFRAM | 906 | P55160 | |
| IRKLMRKAELMGIST | 576 | O94880 | |
| IMVTILKMSSTAGRK | 221 | Q8NH89 | |
| TIVMMTRLEEKSRIK | 1486 | Q13332 | |
| VVMLTKLREMGREKC | 1776 | Q13332 | |
| RARRKTAKMLMVVLL | 291 | O43613 | |
| ATKMMSRRKILLLVL | 11 | Q96A11 | |
| RVKMMTTLRTGLRFK | 1171 | Q13535 | |
| TRMLTKIIRDKGTML | 166 | P31327 | |
| MGGRKVMSISIRLKV | 181 | P07333 | |
| MRAVKSVLVMAGSLK | 1646 | Q9C0G6 | |
| IARVLKLLKMAVGMR | 1716 | O43497 | |
| KLLKMAVGMRALLDT | 1721 | O43497 | |
| IGVLMIRDSKVKMRF | 151 | Q6ZN84 | |
| MNKLLTMGSFKRITL | 886 | Q8IZS8 | |
| IDAAIVRIMKMRKTL | 696 | Q13619 | |
| VRIMKMRKTLGHNLL | 701 | Q13619 | |
| RIARVLKLLKMATGM | 1591 | Q9P0X4 | |
| GVCRTRTMKIIMKVG | 151 | P98172 | |
| MKSITRMKRIFYRIG | 131 | Q9NPH9 | |
| EKMMRLGGRLVLNTK | 41 | Q9NZK5 | |
| MNRILRSLGSKMKFL | 911 | Q68D51 | |
| SRKMKVLESLIGMIQ | 76 | Q8WV07 | |
| MRQKMDVKSALSIVR | 141 | P51452 | |
| MLTGRSIRADRAKKM | 201 | P40939 | |
| YRRILMGSTLRKRKM | 231 | P10644 | |
| YRRILMGSTLRKRKM | 231 | P31321 | |
| KRGSIVSKLLASMMC | 121 | O60256 | |
| SIISLIMGMKFFRIK | 266 | Q5TBA9 | |
| KVAVLVMGRMKREIT | 741 | O95479 | |
| RIARVLKLLKMATGM | 1721 | O95180 | |
| MERRLKGSLKMLRKS | 576 | Q8IX30 | |
| MKVTSLDGRQLRKML | 1 | Q16690 | |
| DAAIVRIMKMRKTLS | 851 | Q13620 | |
| SAMLLQRLKMKGIRN | 301 | O75928 | |
| RILSGVVTKMKMQRT | 71 | P62280 | |
| TRMILFKMLTRGIIT | 166 | Q9BRS2 | |
| MMLKGITRLISRIHK | 1 | P51398 | |
| IMNMKETTKRVRLGP | 441 | Q15542 | |
| MRTRVAGKTKLLAIM | 871 | Q9Y5W8 | |
| ILMRILYGRMKNKTG | 1011 | O75691 | |
| SLRGKVVVLMGKNTM | 46 | Q8NHW5 | |
| GKGMRTRQRMLKSLA | 631 | Q9HCB6 | |
| MVGEEKMSLRNRLSK | 1 | P35610 | |
| KKLSLSALGAIRMAM | 411 | Q9UIG8 | |
| LQMFKVTMSRILRLK | 246 | O76064 | |
| MIRGENMSKILKARS | 236 | O43776 | |
| EKKMGTTRRAFLMEL | 41 | P04053 | |
| SIQKRAVRKMSVMGR | 736 | Q7Z3K3 | |
| RRLVMGLREVTKHMK | 716 | Q93073 | |
| MAMASVKLLAGVLRK | 1 | Q9P0P8 | |
| MAEANVSLRRMKKIL | 401 | Q96J65 | |
| TERLIKAKLRSIMMS | 251 | Q8WYL5 | |
| MEVLKTRMALRKTGQ | 301 | Q6KCM7 | |
| RVKVGMTVHCRIMKI | 1256 | Q7KZ85 | |
| KLRMIAKEIRHVGRM | 896 | Q9Y4G8 | |
| QLKRSQTRMAKMGIL | 211 | I1YAP6 | |
| MRKMLAAVSRVLSGA | 1 | P08559 | |
| TGMKGKRLTLKIMVR | 746 | Q9UBZ9 | |
| MLAVRKARRKLRMGT | 1 | Q0VAA5 | |
| IRMTKGITMATAKAV | 2176 | Q9Y490 | |
| TMRMVLKSKRRVSVL | 301 | Q6ZV50 | |
| MAILEALMTVRKKRA | 246 | Q5VZP5 | |
| LMSDLFNKLVMRRKG | 421 | A8MWX3 | |
| LPKIQRSEGKTRMAM | 806 | O94804 | |
| LAAMKLMTSLVRVAL | 96 | Q8TBR4 | |
| PSRMAQTIMKARLKG | 11 | Q9Y5K8 | |
| SFAMGTRMLKEILKI | 1351 | Q8IZH2 | |
| LMSDLFNKLVMRRKG | 406 | C4AMC7 | |
| MFKGLESLKTLMLRS | 601 | O94813 | |
| LCRITGMKEMLRKFS | 271 | Q8N9V2 | |
| LVGLVSMILMRTLRK | 236 | Q9HD45 | |
| ISTKELGKVMRMLGQ | 36 | P63316 | |
| MSDLFNKLVMRRKGI | 391 | Q9NQA3 | |
| VGMVKSLTRSSMVKL | 621 | O76024 | |
| LLTNRGSKMFKLRQM | 51 | Q9NP98 | |
| ITDLRGMLKRLKRMR | 231 | Q00872 |